NEW YORK, April 1, 2022 /PRNewswire/ -- The Respiratory Devices Market size in Australia is expected to grow by USD 458.32 million from 2021 to 2026, at a CAGR of 5.44% during the forecast period, according to Technavio. The report offers an up-to-date analysis to know the exact growth variance and the Y-O-Y growth rate Request a free sample report.
The increase in patient awareness, increasing prevalence of respiratory disorders, and increasing research on combination therapies will offer immense growth opportunities. However, high costs of respiratory diagnostic products, stringent regulations associated with medical imaging equipment, and a lack of skilled and trained professionals in laboratories will challenge the growth of the market participants.
To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The Respiratory Devices Market in Australia 2022-2026: Segmentation
The Respiratory Devices Market in Australia is segmented as below:
Learn more about the additional trends impacting the future of the market and the positive and negative consequences on the businesses., download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR72705
Respiratory Devices Market in Australia 2022-2026: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our respiratory devices market in Australia report covers the following areas:
This study identifies the increase in patient awareness as one of the prime reasons driving the respiratory devices market in Australia's growth during the next few years.
Respiratory Devices Market in Australia 2022-2026: Vendor Analysis
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
Find additional highlights on the growth strategies adopted by vendors and their product offerings, Read Free Sample Report.
Respiratory Devices Market in Australia Value Chain Analysis
The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the healthcare equipment market includes the following core components:
Download a free sample for more highlights and insights into Parent market Analysis.
Respiratory Devices Market in Australia 2022-2026: Key Highlights
We offer USD 1,000 worth of FREE customization at the time of purchase. Speak to our Analyst now!
Related Reports:
Intrapartum Monitoring Devices Market by Product and Geography - Forecast and Analysis 2022-2026
Respiratory Devices Market Scope in Australia |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.44% |
Market growth 2022-2026 |
$ 458.32 million |
Market structure |
Fragmented |
YoY growth (%) |
4.29 |
Regional analysis |
Australia |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Bellavista Medical ANZ, Bird Healthcare Pty Ltd, Chart Industries Inc., Dragerwerk AG and Co. KGaA, Fairmont Medical Products Pty Ltd., Fisher and Paykel Healthcare Corp. Ltd., General Electric Co., GlaxoSmithKline Plc, Invacare Corp, and Medical Depot Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table Of Contents:
1. Executive Summary
1.1 Market Overview
Exhibit 01: Key Finding 1
Exhibit 02: Key Finding 2
Exhibit 03: Key Finding 6
Exhibit 04: Key Finding 5
Exhibit 05: Key Finding 7
2. Market Landscape
2.1 Market ecosystem
2.1.1 Parent market
Exhibit 06: Parent market
Exhibit 07: Market Characteristics
2.2 Value chain analysis
Exhibit 08: Value chain analysis: Healthcare Equipment
2.2.1 Research and development
2.2.2 Inputs
2.2.3 Operations
2.2.4 Distribution
2.2.5 Marketing and sales
2.2.6 Post-sales and services
2.2.7 Industry innovations
3. Market Sizing
3.1 Market definition
Exhibit 09: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 10: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021 - 2026
3.4.1 Estimating growth rates for emerging and high-growth markets
3.4.2 Estimating growth rates for mature markets
Exhibit 11: Global - Market size and forecast 2021 - 2026 ($ million)
Exhibit 12: Global market: Year-over-year growth 2021 - 2026 (%)
4. Five Forces Analysis
4.1 Five Forces Summary
Exhibit 13: Five forces analysis 2021 & 2026
4.2 Bargaining power of buyers
Exhibit 14: Bargaining power of buyers
4.3 Bargaining power of suppliers
Exhibit 15: Bargaining power of suppliers
4.4 Threat of new entrants
Exhibit 16: Threat of new entrants
4.5 Threat of substitutes
Exhibit 17: Threat of substitutes
4.6 Threat of rivalry
Exhibit 18: Threat of rivalry
4.7 Market condition
Exhibit 19: Market condition - Five forces 2021
5. Market Segmentation by End-user
5.1 Market segments
The segments covered in this chapter are:
Exhibit 20: End-user - Market share 2021-2026 (%)
5.2 Comparison by End-user
Exhibit 21: Comparison by End-user
5.3 Hospitals - Market size and forecast 2021-2026
Exhibit 22: Hospitals - Market size and forecast 2021-2026 ($ million)
Exhibit 23: Hospitals - Year-over-year growth 2021-2026 (%)
5.4 Clinics - Market size and forecast 2021-2026
Exhibit 24: Clinics - Market size and forecast 2021-2026 ($ million)
Exhibit 25: Clinics - Year-over-year growth 2021-2026 (%)
5.5 Ambulatory care services - Market size and forecast 2021-2026
Exhibit 26: Ambulatory care services - Market size and forecast 2021-2026 ($ million)
Exhibit 27: Ambulatory care services - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by End-user
Exhibit 28: Market opportunity by End-user
6. Market Segmentation by Type
6.1 Market segments
The segments covered in this chapter are:
Exhibit 29: Type - Market share 2021-2026 (%)
6.2 Comparison by Type
Exhibit 30: Comparison by Type
6.3 Diagnostic and monitoring devices - Market size and forecast 2021-2026
Exhibit 31: Diagnostic and monitoring devices - Market size and forecast 2021-2026 ($ million)
Exhibit 36: Full truckload - Year-over-year growth 2021-2026 (%)
6.4 Therapeutic devices - Market size and forecast 2021-2026
Exhibit 33: Therapeutic devices - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Therapeutic devices - Year-over-year growth 2021-2026 (%)
6.5 Disposables - Market size and forecast 2021-2026
Exhibit 35: Disposables - Market size and forecast 2021-2026 ($ million)
Exhibit 36: Disposables - Year-over-year growth 2021-2026 (%)
6.6 Market opportunity by Type
Exhibit 37: Market opportunity by Type
7. Customer Landscape
7.1 Overview
Exhibit 38: Customer landscape
8. Drivers, Challenges, and Trends
8.1 Market drivers
8.1.1 Increase in patient awareness
8.1.2 Increasing prevalence of respiratory disorders
8.1.3 Increasing research on combination therapies
8.2 Market challenges
8.2.1 High costs of respiratory diagnostic products
8.2.2 Stringent regulations associated with medical imaging equipment
8.2.3 Lack of skilled and trained professionals in laboratories
Exhibit 39: Impact of drivers and challenges
8.3 Market trends
8.3.1 Expanding research through new clinical trials and approaches
8.3.2 Integration of AI with medical imaging
8.3.3 Initiatives by government and non-profit organizations to diagnose Respiratory Syncytial Virus (RSV)
9. Vendor Landscape
9.1 Overview
Exhibit 40: Vendor landscape
9.2 Landscape disruption
Exhibit 41: Landscape disruption
Exhibit 42: Industry risks
9.3 Competitive landscape
10. Vendor Analysis
10.1 Vendors covered
Exhibit 43: Vendors covered
10.2 Market positioning of vendors
Exhibit 44: Market positioning of vendors
10.3 Bellavista Medical ANZ
Exhibit 45: Bellavista Medical ANZ - Overview
Exhibit 46: Bellavista Medical ANZ - Product and service
Exhibit 47: Bellavista Medical ANZ - Key offerings
10.4 Bird Healthcare Pty Ltd
Exhibit 48: Bird Healthcare Pty Ltd - Overview
Exhibit 49: Bird Healthcare Pty Ltd - Product and service
Exhibit 50: Bird Healthcare Pty Ltd - Key offerings
10.5 Chart Industries Inc.
Exhibit 51: Chart Industries Inc. - Overview
Exhibit 52: Chart Industries Inc. - Business segments
Exhibit 53: Chart Industries Inc. - Key offerings
Exhibit 54: Chart Industries Inc. – Key news
Exhibit 55: Chart Industries Inc. - Segment focus
10.6 Dragerwerk AG and Co. KGaA
Exhibit 57: Dragerwerk AG and Co. KGaA - Business segments
Exhibit 58: Dragerwerk AG and Co. KGaA - Key offerings
Exhibit 59: Dragerwerk AG and Co. KGaA - Segment focus
10.7 Fairmont Medical Products Pty Ltd.
Exhibit 60: Fairmont Medical Products Pty Ltd. - Overview
Exhibit 61: Fairmont Medical Products Pty Ltd. - Product and service
Exhibit 62: Fairmont Medical Products Pty Ltd. - Key offerings
10.8 Fisher and Paykel Healthcare Corp. Ltd.
Exhibit 63: Fisher and Paykel Healthcare Corp. Ltd. - Overview
Exhibit 64: Fisher and Paykel Healthcare Corp. Ltd. - Business segments
Exhibit 65: Fisher and Paykel Healthcare Corp. Ltd. - Key offerings
Exhibit 66: Fisher and Paykel Healthcare Corp. Ltd. - Segment focus
10.9 General Electric Co.
Exhibit 67: General Electric Co. - Overview
Exhibit 68: General Electric Co. - Business segments
Exhibit 69: General Electric Co. - Key offerings
Exhibit 69: General Electric Co. - Key offerings
Exhibit 71: General Electric Co. - Segment focus
10.10 GlaxoSmithKline Plc
Exhibit 72: GlaxoSmithKline Plc - Overview
Exhibit 73: GlaxoSmithKline Plc - Business segments
Exhibit 74: GlaxoSmithKline Plc - Key offerings
Exhibit 75: GlaxoSmithKline Plc – Key news
Exhibit 76: GlaxoSmithKline Plc - Segment focus
10.11 Invacare Corp
Exhibit 77: Invacare Corp - Overview
Exhibit 78: Invacare Corp - Business segments
Exhibit 79: Invacare Corp - Key offerings
Exhibit 80: Invacare Corp – Key news
Exhibit 81: Invacare Corp - Segment focus
10.12 Medical Depot Inc.
Exhibit 82: Medical Depot Inc. - Overview
Exhibit 83: Medical Depot Inc. - Product and service
Exhibit 84: Medical Depot Inc. - Key offerings
11. Appendix
11.1 Scope of the report
11.1.1 Market definition
11.1.2 Objective
11.1.3 Notes and caveats
11.2 Currency conversion rates for US$
Exhibit 85: Currency conversion rates for US$
11.3 Research Methodology
Exhibit 86: Research Methodology
Exhibit 87: Validation techniques employed for market sizing
Exhibit 88: Information sources
11.4 List of abbreviations
Exhibit 89: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article